Literature DB >> 28653404

Neuroanatomical Characteristics Associated With Response to Deep Brain Stimulation of the Nucleus Basalis of Meynert for Alzheimer's Disease.

Juan Carlos Baldermann1, Katja Hardenacke1, Xiaochen Hu1, Phillip Köster1, Andreas Horn2, Hans-Joachim Freund3, Karl Zilles4,5, Volker Sturm6, Veerle Visser-Vandewalle6, Frank Jessen1,7, David Maintz8, Jens Kuhn1.   

Abstract

OBJECTIVES: First reports on the application of deep brain stimulation (DBS) of the Nucleus basalis of Meynert (NBM) showed feasibility and safety of the intervention in patients with Alzheimer´s disease. However, clinical effects vary and the mechanisms of actions are still not well understood. The aim of this study was to characterize neuroimaging changes that are associated with the responsiveness to the treatment.
MATERIALS AND METHODS: We examined preoperative T1-weighted MR images of ten patients with Alzheimer's disease (AD) treated with DBS of the NBM and correlated the clinical outcome with volumetric differences of cortical thickness. Subsequently, we sought to identify brain regions that carry out the clinical effects by correlating the outcome with streamlines connected to the volume of activated tissue. Clinical assessments at baseline, 6 and 12 months after the intervention included the AD Assessment Scale as well as the mini mental status examination.
RESULTS: A fronto-parieto-temporal pattern of cortical thickness was found to be associated with beneficial outcome. Modulation of streamlines connected to left parietal and opercular cortices was associated with better response to the intervention.
CONCLUSION: Our results indicate that patients with less advanced atrophy may profit from DBS of the NBM. We conclude that beneficial effects of the intervention are related to preserved fronto-parieto-temporal interplay.
© 2017 International Neuromodulation Society.

Entities:  

Keywords:  Alzheimer's disease; Nucleus basalis of Meynert; cortical thickness; deep brain stimulation

Mesh:

Year:  2017        PMID: 28653404     DOI: 10.1111/ner.12626

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  8 in total

1.  Orientation selective DBS of entorhinal cortex and medial septal nucleus modulates activity of rat brain areas involved in memory and cognition.

Authors:  Lin Wu; Antonietta Canna; Omar Narvaez; Jun Ma; Sheng Sang; Lauri J Lehto; Alejandra Sierra; Heikki Tanila; Yuan Zhang; Olli Gröhn; Walter C Low; Pavel Filip; Silvia Mangia; Shalom Michaeli
Journal:  Sci Rep       Date:  2022-05-20       Impact factor: 4.996

2.  Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment.

Authors:  Siming Rong; Yan Li; Bing Li; Kun Nie; Piao Zhang; Tongtong Cai; Mingjin Mei; Lijuan Wang; Yuhu Zhang
Journal:  Quant Imaging Med Surg       Date:  2021-04

Review 3.  A circuit view of deep brain stimulation in Alzheimer's disease and the possible mechanisms.

Authors:  Danfang Yu; Huanhuan Yan; Jun Zhou; Xiaodan Yang; Youming Lu; Yunyun Han
Journal:  Mol Neurodegener       Date:  2019-08-08       Impact factor: 14.195

4.  Combined subthalamic and nucleus basalis of Meynert deep brain stimulation for Parkinson's disease with dementia (DEMPARK-DBS): protocol of a randomized, sham-controlled trial.

Authors:  Christine Daniels; Frank Steigerwald; Philipp Capetian; Cordula Matthies; Uwe Malzahn; Peter U Heuschmann; Jens Volkmann
Journal:  Neurol Res Pract       Date:  2020-10-19

Review 5.  Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.

Authors:  Cody Slater; Qi Wang
Journal:  Clin Transl Med       Date:  2021-04

6.  Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson's Disease Dementia: A 36 Months Follow Up Study.

Authors:  Davide Cappon; James Gratwicke; Ludvic Zrinzo; Harith Akram; Jonathan Hyam; Marwan Hariz; Patricia Limousin; Thomas Foltynie; Marjan Jahanshahi
Journal:  Mov Disord Clin Pract       Date:  2022-07-27

7.  Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.

Authors:  Chen Pei Lin; Irene Frigerio; Baayla D C Boon; Zihan Zhou; Annemieke J M Rozemuller; Femke H Bouwman; Menno M Schoonheim; Wilma D J van de Berg; Laura E Jonkman
Journal:  Brain       Date:  2022-08-27       Impact factor: 15.255

Review 8.  Deep Brain Stimulation: A Potential Treatment for Dementia in Alzheimer's Disease (AD) and Parkinson's Disease Dementia (PDD).

Authors:  Qing Lv; Ailian Du; Wenshi Wei; Yuanyuan Li; Gailing Liu; Xiao Ping Wang
Journal:  Front Neurosci       Date:  2018-05-29       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.